Sánchez-Rodríguez, Carmen
Gago-Veiga, Ana Beatriz http://orcid.org/0000-0002-0038-3406
García-Azorín, David http://orcid.org/0000-0002-3132-1064
Guerrero-Peral, Ángel Luis http://orcid.org/0000-0001-7493-6002
Gonzalez-Martinez, Alicia http://orcid.org/0000-0002-1228-1503
Funding for this research was provided by:
Instituto de Salud Carlos III (PMP22/00158, PMP22/00158, PMP22/00158, CM21/00178)
Article History
Accepted: 16 October 2023
First Online: 24 October 2023
Compliance with Ethical Standards
:
: Ethics approval was not required for this review.
: Carmen Sánchez-Rodríguez has no relevant financial or non-financial interests to disclose. Ana Beatriz Gago-Veiga has received honoraria from Lilly, Novartis, TEVA, Abbvie-Allergan, Exeltis, and Chiesi. David García-Azorín reports payment or honoraria for lectures from Teva, Lilly, Allergan-Abbvie, Novartis, and Lundbeck and has served on an advisory board for Allergan-Abbvie. Ángel Luis Guerrero-Peral has received honoraria from Lilly, TEVA, Novartis, Allergan-Abbvie, and Exeltis and research support from Allegan-Abbvie and TEVA. Alicia Gonzalez-Martinez has received speaker honoraria from TEVA.
: This article does not contain any studies with human or animal subjects performed by any of the authors.